Personalizing prostate specific antigen testing may improve specificity, reduce biopsies
Monday, April 15, 2013 - 11:50
in Health & Medicine
Genetic variants have been identified which can increase serum prostate specific antigen (PSA) concentrations and prostate cancer risk. A new study reports that correcting PSA levels for these genetic variants can have significant consequences, including avoiding unnecessary biopsies for some men and eliminating false complacency for others.